DK0552280T3 - Inhibering af viral replikation - Google Patents
Inhibering af viral replikationInfo
- Publication number
- DK0552280T3 DK0552280T3 DK91919581.8T DK91919581T DK0552280T3 DK 0552280 T3 DK0552280 T3 DK 0552280T3 DK 91919581 T DK91919581 T DK 91919581T DK 0552280 T3 DK0552280 T3 DK 0552280T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibition
- viral replication
- dna
- cell
- viral
- Prior art date
Links
- 230000005764 inhibitory process Effects 0.000 title 1
- 230000029812 viral genome replication Effects 0.000 title 1
- 108020004414 DNA Proteins 0.000 abstract 2
- 108091033380 Coding strand Proteins 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 108010052104 Viral Regulatory and Accessory Proteins Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- AIDS & HIV (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59525390A | 1990-10-09 | 1990-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0552280T3 true DK0552280T3 (da) | 1995-08-28 |
Family
ID=24382446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91919581.8T DK0552280T3 (da) | 1990-10-09 | 1991-10-09 | Inhibering af viral replikation |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0552280B1 (fr) |
| JP (1) | JPH06504429A (fr) |
| AT (1) | ATE124457T1 (fr) |
| AU (1) | AU652006B2 (fr) |
| CA (1) | CA2093816A1 (fr) |
| DE (1) | DE69110897T2 (fr) |
| DK (1) | DK0552280T3 (fr) |
| ES (1) | ES2073777T3 (fr) |
| WO (1) | WO1992006192A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3351476B2 (ja) * | 1993-01-22 | 2002-11-25 | 三菱化学株式会社 | リン脂質誘導体及びそれを含有するリポソーム |
| DE69435244D1 (de) * | 1993-12-17 | 2009-11-26 | Novavax Inc | Verfahren zur übertragung eines biologisch aktiven materials an eine zelle |
| EP1852121A3 (fr) | 1994-08-29 | 2007-11-21 | Wake Forest University | Analogues de lipides pour traiter des infections virales |
| US7135584B2 (en) | 1995-08-07 | 2006-11-14 | Wake Forest University | Lipid analogs for treating viral infections |
| US6776986B1 (en) | 1996-06-06 | 2004-08-17 | Novartis Ag | Inhibition of HIV-1 replication by antisense RNA expression |
| US7026469B2 (en) | 2000-10-19 | 2006-04-11 | Wake Forest University School Of Medicine | Compositions and methods of double-targeting virus infections and cancer cells |
| US7309696B2 (en) | 2000-10-19 | 2007-12-18 | Wake Forest University | Compositions and methods for targeting cancer cells |
| CN100469131C (zh) | 2001-08-31 | 2009-03-11 | 汤姆森许可公司 | 实现条件存取系统和传输、接收及处理内容的方法和设备 |
| EP1663315B1 (fr) * | 2003-09-17 | 2011-01-05 | Rodos BioTarget GmbH | Preparations lipide-medicament pour l'administration ciblee de medicaments aux cellules immunitaires myeloides et lymphoides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3853139T2 (de) * | 1987-06-26 | 1995-06-14 | Syntro Corp | Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung. |
| DE3744785A1 (de) * | 1987-12-11 | 1989-08-17 | Theurer Karl Eugen | Verwendung von ruecklaeufigen spiegelbildlichen anti-sense-nucleinsaeuren gegen krebserkrankungen |
| ATE132190T1 (de) * | 1988-02-26 | 1996-01-15 | Worcester Found Ex Biology | Hemmung von htlv-iii durch exogene oligonukleotide |
-
1991
- 1991-10-09 DE DE69110897T patent/DE69110897T2/de not_active Expired - Fee Related
- 1991-10-09 CA CA002093816A patent/CA2093816A1/fr not_active Abandoned
- 1991-10-09 AT AT91919581T patent/ATE124457T1/de not_active IP Right Cessation
- 1991-10-09 ES ES91919581T patent/ES2073777T3/es not_active Expired - Lifetime
- 1991-10-09 EP EP91919581A patent/EP0552280B1/fr not_active Expired - Lifetime
- 1991-10-09 DK DK91919581.8T patent/DK0552280T3/da active
- 1991-10-09 AU AU88759/91A patent/AU652006B2/en not_active Ceased
- 1991-10-09 WO PCT/US1991/007550 patent/WO1992006192A1/fr not_active Ceased
- 1991-10-09 JP JP3518313A patent/JPH06504429A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06504429A (ja) | 1994-05-26 |
| EP0552280B1 (fr) | 1995-06-28 |
| DE69110897D1 (de) | 1995-08-03 |
| AU652006B2 (en) | 1994-08-11 |
| ATE124457T1 (de) | 1995-07-15 |
| EP0552280A1 (fr) | 1993-07-28 |
| WO1992006192A1 (fr) | 1992-04-16 |
| ES2073777T3 (es) | 1995-08-16 |
| AU8875991A (en) | 1992-04-28 |
| DE69110897T2 (de) | 1995-11-30 |
| CA2093816A1 (fr) | 1992-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69532369D1 (de) | Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strange-RNS-Virus | |
| DE69535125D1 (de) | Impstoff gegen felines immunodefizienz-virus | |
| DE69819167D1 (de) | Modifizierter, das dorsalgewebe beeinflussender faktor | |
| DK0531370T3 (da) | Inhibering af virusinfektion | |
| ES2140418T3 (es) | Flavivirus quimericos y/o flavivirus de crecimiento restringido. | |
| ATE420190T1 (de) | Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen | |
| DK0552280T3 (da) | Inhibering af viral replikation | |
| ATE209685T1 (de) | Gegen plrv-infektion resistente pflanzen | |
| DK0599868T3 (da) | Polyphenoloxidase-gener | |
| AU2001279581A1 (en) | Medicament comprising a dna sequence, which codes for the rna-binding koc protein, and comprising a koc protein or dna sequence of the koc promoter | |
| DE60233875D1 (de) | Attenuierter circovirus | |
| DE69534945D1 (de) | Impfstoff für die infektiöse peritonitis der katzen | |
| ATE442441T1 (de) | Virale expressionsvektoren für pflanzen | |
| ES2367245T8 (es) | Virus recombinante que expresa adn foráneo que codifica cd80 felino, cd28 felino, ctla-4felino o cd86 felino y usos del mismo. | |
| DE50304603D1 (de) | Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze | |
| DE69733948D1 (de) | In vivo herstellung von replicativen molekülen | |
| WO1998042847A3 (fr) | Proteines a capside principale de papillomavirus et leur utilisation a des fins de diagnostic, de therapie et de vaccination | |
| WO2002083896A3 (fr) | Virus recombinant segmente a polarite negative contenant un segment d'arnv bicistronique avec duplication de sa sequence laterale 3' non codante, et vaccins et compositions therapeutiques le contenant | |
| WO2000042063A3 (fr) | Peptides pour l'inhibition des proteines noyaux du virus de l'hepatite b | |
| WO2004027066A3 (fr) | Protéine recombinante chimérique et diagnostic in vitro du hiv | |
| WO2001085770A3 (fr) | Virus sentinelle ii | |
| FI893346A0 (fi) | Icke-reverterande rna-virus. |